ACP
EXAS

Altitude Crest Partners’s Exact Sciences EXAS Stock Holding History

Altitude Crest Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-99,130
Closed -$7.33M – 33
2023
Q4 		$7.33M Buy
+99,130
New +$6.5M 4.91% 9

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Altitude Crest Partners's EXAS Position: Q1 2024 in Review

Altitude Crest Partners sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 99,130 shares — an estimated $7.33M sold.

Altitude Crest Partners first reported a position in EXAS in Q4 2023 and held it in 1 quarter. The position peaked at $7.33M in Q4 2023. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Altitude Crest Partners reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Altitude Crest Partners sold 99,130 Exact Sciences shares in Q1 2024, an estimated $7.33M.
  • Altitude Crest Partners first reported a position in Exact Sciences in Q4 2023 and held it in 1 quarter.
  • Altitude Crest Partners's Exact Sciences position peaked at $7.33M in Q4 2023.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Altitude Crest Partners's 13F filing for Q1 2024, filed 14 May 2024.